ING Groep NV Sells 160,300 Shares of Amedisys, Inc. (NASDAQ:AMED)

ING Groep NV lessened its holdings in Amedisys, Inc. (NASDAQ:AMED) by 72.1% during the third quarter, Holdings Channel.com reports. The firm owned 62,000 shares of the health services provider’s stock after selling 160,300 shares during the quarter. ING Groep NV’s holdings in Amedisys were worth $5,984,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of AMED. BNP Paribas Financial Markets lifted its position in shares of Amedisys by 111.7% during the 1st quarter. BNP Paribas Financial Markets now owns 12,050 shares of the health services provider’s stock valued at $1,111,000 after buying an additional 6,358 shares in the last quarter. Swiss National Bank grew its stake in shares of Amedisys by 5.4% during the first quarter. Swiss National Bank now owns 64,400 shares of the health services provider’s stock valued at $5,935,000 after buying an additional 3,300 shares during the last quarter. State Board of Administration of Florida Retirement System lifted its position in shares of Amedisys by 5.3% during the first quarter. State Board of Administration of Florida Retirement System now owns 38,403 shares of the health services provider’s stock worth $3,539,000 after purchasing an additional 1,923 shares during the last quarter. Covestor Ltd raised its stake in shares of Amedisys by 134.2% during the first quarter. Covestor Ltd now owns 780 shares of the health services provider’s stock valued at $72,000 after acquiring an additional 447 shares in the last quarter. Finally, Alpine Global Management LLC bought a new position in shares of Amedisys during the 1st quarter worth $922,000. Hedge funds and other institutional investors own 94.36% of the company’s stock.

Amedisys Stock Down 0.3 %

Shares of NASDAQ:AMED opened at $90.05 on Friday. The company has a market capitalization of $2.95 billion, a PE ratio of 35.73, a P/E/G ratio of 1.86 and a beta of 0.78. Amedisys, Inc. has a twelve month low of $89.55 and a twelve month high of $98.95. The firm has a 50 day simple moving average of $96.04 and a 200-day simple moving average of $95.80. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05.

Amedisys (NASDAQ:AMED) last posted its quarterly earnings results on Wednesday, November 6th. The health services provider reported $1.00 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.19). The business had revenue of $587.67 million during the quarter, compared to analyst estimates of $586.75 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The firm’s quarterly revenue was up 5.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.98 earnings per share. On average, equities analysts predict that Amedisys, Inc. will post 4.66 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

AMED has been the topic of several analyst reports. Deutsche Bank Aktiengesellschaft lowered Amedisys from a “buy” rating to a “hold” rating and set a $101.00 target price on the stock. in a research note on Monday, July 29th. Cantor Fitzgerald reissued a “neutral” rating and set a $101.00 target price on shares of Amedisys in a report on Thursday, July 25th. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, Amedisys presently has a consensus rating of “Hold” and an average price target of $100.67.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.